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Introduction 
1.1 Purpose  
This report provides a progress update on the Government's Tackling Methamphetamine: an Action Plan (the 
Action Plan). It specifically: 
 records changes against the Action Plan's baseline data of 2008 or 2009, and 
 details progress on the Action Plan's activities. 
 
1.2 Latest data and reports on progress provided six monthly 
Reports on progress against the Action Plan are provided to the Prime Minister and the Ministers of Justice, Health, 
Police, Corrections, Customs and Māori Affairs every six months. DPMC coordinates the reporting process and the 
Methamphetamine Steering Group, made up of senior officials from the relevant agencies approves the reports. 
The Interagency Committee on Drugs will oversee this report in future, although DPMC will continue to lead it.  
 
This Indicators and Progress Report uses the same streamlined Indicators and Progress Report introduced with 
the April 2013 Report. The data sources remain the same.  
 
1.3 Data should be used with caution 
Descriptions of data sources can be found in Tackling Methamphetamine: Baseline Indicators Report at 
http://www.beehive.govt.nz/sites/all/files/baseline_indicators.pdf. It should be noted that, due to various recording 
and release dates, some data are provisional and other data may have been collected but not yet analysed. 
Therefore some changes may be made in subsequent reporting if necessary. Annex 1 has a high-level description 
of the differences between some of the key data sources. 
 
1.4 Overview of expected results and indicators 
An overview of the actions, expected results, and the indicators set can be found in the Action Plan available at 
http://www.beehive.govt.nz/sites/all/files/ActionPlan.pdf. Previous Progress and Indicator Reports can be found at 
http://www.dpmc.govt.nz/dpmc/publications/methamphetamine. The following page provides an outline of the 
expected results from the Action Plan and how the indicators set fits within these.  
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Part 1: Progress on cross-agency actions 
 
 
Action Comment  
Crack-down on precursors 
1 The Precursor Working Group (PWG) to 
investigate stronger controls on other 
precursor chemicals and products used in 
the manufacture of methamphetamine. 
The National Drug Intelligence Bureau has submitted an 
application to the EPA for consideration. The PWG 
reviewed the application on 18 November 2013. 
2 Expand the programme of detailed chemical 
and purity analysis of drug seizures. 
The results of the Drug Signature pilot programme to 
date are outlined on page 7. CPRA funding will expand 
the programme, including improving tracing and source 
identification. 
Break supply chains 
3 Allocate, via the normal Budget process 
monies forfeited under the Criminal 
Proceeds (Recovery) Act 2009 (CPRA) to 
fund expansion of alcohol and other drug 
treatment, including methamphetamine and 
continuing care services and Police/ 
Customs initiatives to fight organised criminal 
groups dealing in methamphetamine and 
other drugs. 
The Prime Minister has announced the first set of 
proposals to receive CPRA funding (see page 13). 
Proposals that relate to actions in the plan are outlined in 
this table. 
 
Police will receive some CPRA funding for legal costs for 
civil recovery actions under the CPRA. 
4 Annually review and action a Police 
Methamphetamine Control Strategy (MCS). 
Police launched the MCS in 2009. It is a restricted 
document, reviewed annually to ensure that it anticipates 
and responds to emerging trends in the 
methamphetamine market. The 2013/2014 MCS has the 
same focus as the 2012/2013 strategy on: enhancing 
national intelligence, targeting highest risk manufacturers 
and suppliers, and using tailored interventions to prevent 
and combat manufacture and supply. 
5 Introduce measures to increase interception 
rates of methamphetamine and precursors at 
the border through better risk profiling and 
targeting.  
Customs has initiated a new multi-year sequence of 
operations and initiatives, including testing non-traditional 
import pathways and targeting new routings. CPRA 
funding will enhance frontline screening capability. 
6 Work with China to reduce the supply of 
methamphetamine and precursors to New 
Zealand. 
The Prime Minister highlighted the need for increased 
engagement between New Zealand and Chinese 
enforcement agencies in a visit to China in April 2013. 
During this visit, a Memorandum of Arrangement (MOA) 
on precursor controls was signed between China and 
New Zealand. At the Sino - New Zealand Crime 
Cooperation Bilateral in September 2013, there was 
discussion about operational progress made since the 
MOA was signed and processes for drug specialists to 
meet and discuss operational tactics.  
7 Introduce measures to increase interception 
rates of cash associated with drug supply. 
CPRA funding will be used to train Police search dogs to 
detect cash. This will prevent funds being reinvested in 
the supply and manufacture of controlled drugs and 
organised criminal activity. 
Provide better routes into treatment 
8 Maintain the capacity of alcohol and drug 
treatment services to provide more spaces 
for methamphetamine users. 
 
As a result of the Action Plan, 60 residential treatment 
beds for methamphetamine users have become 
operational (in addition to services purchased by DHBs) 
as have an additional 20 social detox beds. Since 
November 2009, over 660 individuals have entered 
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Action Comment  
residential treatment through the dedicated 
methamphetamine pathway. Over 600  
people have also accessed community-based detox 
services.  
 
CPRA funding will provide additional supported and 
residential treatment beds in Auckland for participants 
(including but not limited to methamphetamine users) in 
the Alcohol and Other Drug Treatment (AODT) Court. 
9 Improve routes into treatment through 
increased referral of methamphetamine 
users at an early stage of contact with the 
justice system.  
 
Improve routes into treatment through 
contact with frontline government funded 
services.  
The number and proportion of offenders with 
methamphetamine convictions receiving alcohol and 
drug assessments as a condition of sentence continues 
to increase from 8% in 2004 to around 20% in 2012.  
 
The five year AODT Court Pilot commenced in the 
Auckland and Waitakere District Courts on 1 November 
2012. As at 11 October, a total of 63 participants had 
been accepted.  CPRA funding will fund counsel costs 
for the AODT Court next year.   
 
Following training in 2012, prison nurses and case 
managers are now routinely delivering AOD screenings 
and brief interventions at all 16 prison sites.  In the year 
to June 2013, Corrections delivered 1,168 AOD 
screenings, 1,026 prisoners participated in a Drug 
Treatment Unit programme, and an additional 715 
prisoners received either a brief, intermediate or 
intensive intervention. A total of 4,129 brief AOD 
interventions were delivered by Probation Officers, who 
also facilitated the participation of 6,723 offenders in 
AOD programmes in the community. 
10 Bring forward the review of the Alcoholism 
and Drug Addiction Act 1966 to develop a 
more effective mechanism to mandate 
treatment. 
The Substance Addiction (Compulsory Assessment and 
Treatment) Bill will repeal and replace the Alcoholism 
and Drug Addiction Act 1966 in line with the Law 
Commission’s recommendations. The Bill is category 3 
on the legislative programme, to be passed if possible in 
2013 (but unlikely to be introduced before 2014). 
Support communities 
11 Educate families/whānau and users about 
effects of methamphetamine and how to 
access treatment through a centralised web 
resource. 
MethHelp and Drug Help continue to report high 
frequency of visits, which often lead to direct enquiries 
for MethHelp hard copy resource or referrals to support 
services. The Ministry of Health intends to refresh the 
MethHelp site and resources. 
12 Increase the reach of school community 
interventions targeted to at-risk youth and 
families to reduce demand. 
 
Police School Community Services deliver education 
programmes, including drug education programmes, to 
between 550-600 schools each year. Police is moving 
from a programme approach (i.e. Police-owned and 
published teaching guides) to an approach where Police 
supports schools to develop an intervention to deal with a 
targeted problem in a school (e.g. drug use). The new 
approach will be trialled in 2014. Choice (formerly known 
as DARE) will continue to operate while the new 
approach is being implemented.  
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Action Comment  
 Strengthen governance 
13 Improve official coordination of drug policy. 
 
The Interagency Committee on Drugs (IACD) has been 
refreshed. A key focus is on developing a new National 
Drug Policy. The IACD has also taken on oversight of the 
National Drug Intelligence Bureau, the allocation of the 
Criminal Proceeds Recovery Act funds and the 
development of this plan. 
14 Agencies investigate issues and 
opportunities for Law Commission review of 
the Misuse of Drugs Act 1975 (MoDA). 
 
The Psychoactive Substances Act, which passed in July 
2013, responds to the Law Commission's 
recommendations on emerging substances. Work on the 
rest of the recommendations, including developing a new 
MoDA, will commence once the new National Drug Policy 
is in place (likely to be in early-mid 2014). 
15 Investigate the costs of harmful alcohol and 
other drug use. 
Cost of harm figures were last calculated in 2009.  
 
 
Completed actions  
Action Comment 
End the availability of over the counter 
pseudoephedrine from pharmacies. 
Completed in 2011. 
Expand Customs investigations and technical 
surveillance capacity to enable more effective 
follow up to precursor interceptions at the border.  
Training on use of the new tracking and surveillance 
capabilities has been completed and the equipment has 
been deployed. During surge operations, additional staff 
is assigned to Customs Investigations Units if required.  
Ensure agencies are ready to use new legislative 
tools such as anti-money laundering, organised 
crime, and search and surveillance. 
The Search and Surveillance Act 2012 is now in force. 
Police and other enforcement agencies are using the tools 
in the Act. The first phase of the Anti-Money Laundering 
and Countering Financing of Terrorism (AML/CFT) Act 
2009 came into full effect in June 2013. Agencies are 
prepared to utilise and comply with this legislation.  
Work continues to look at the effectiveness of legislation 
enabling interagency cooperation on the detection and 
targeting of organised crime. This work includes 
facilitating improvements in relation to information 
sharing, increasing financial reporting to Police and 
amending the money laundering offence.  
Increase alcohol and drug workforce capacity and 
capability to respond effectively to 
methamphetamine. 
Workforce initiatives have continued over the past six 
months. In 2013, there are 81 approved bursars 
undertaking study, and 11 intern placements. 
Improve coordination to ensure that Immigration 
is alerted when individuals in breach of permit 
conditions appear to be involved in drug 
operations.  
Immigration staff is routinely attached to work with 
Customs and Police as part of intensive targeting 
operations. 
Strengthen best practice community programmes, 
such as Community Action Youth and Drugs 
(CAYADs). 
CAYADS continue to provide a range of services across 
20 communities. 
Promote the new Drug Education Guidelines. 
 
The Guide to Drug Education in Schools has been 
published on the Ministry of Education website, with links 
to the Guide posted on relevant curriculum and 
leadership sites. 
Evaluate and, if promising, encourage innovative 
local approaches that have demonstrated promise 
for reducing demand for methamphetamine. 
A fifth Hauora Programme, delivering a seven week 
intensive methamphetamine programme to gangs has 
been completed. 
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Part 2: Indicator data for controlling supply 
2.1 Price 
Desired Trend: Supply control leads to an increase in price over time. 
 
Comment: These indicators track changes in the prices that frequent drug users and police detainees report 
paying for methamphetamine. The data show a small but steady increase in the retail price of 
methamphetamine (point price) since around 2008, with reported prices higher in Christchurch than in 
Auckland and Wellington. However, after a steep fall between October 2012 and April 2013, gram prices 
appear to have increased again. According to Police intelligence though, the price of precursors has 
continued to fall. When asked in 2012, 16 per cent of police detainees thought that price has been increasing, 
while 54 per cent thought it was stable and 7 per cent thought it was decreasing. These perceptions have 
been stable over the past 4 years (NZ-ADUM).  
 
Indicator Source Baseline April 2013 data October 2013  
(new data) 
Mean price per point IDMS $96 (2008) $106 (2012) No new data available. 
Median price per point $100 (2008) $100 (2012) No new data available. 
Mean price per point NZ-ADUM $107 (2010) $109 (2012) $109 (2013) 
Median price per point $100 (2010) $100 (2012) $100 (2013) 
 
Mean price per gram IDMS $698 (2008) $678 (2012) No new data available. 
Median price per gram $700 (2008) $700 (2012) No new data available. 
Mean price per gram NZ-ADUM $723 (2010) $691 (2012) $757 (2013) 
Median price per gram $700 (2010) $650 (2012) $700 (2013) 
Mean price per gram 
Police and 
Customs 
intelligence 
reports. 
$800-$1,000  
(Sept 2009) 
$1,000 
(Nov 2012 – Jan 
2013) 
$1,000 
(Feb 2013 – Apr 
2013) 
 
Price per 1000 
capsules (ContacNT) NDIB 
$12,000-$16,000 
(2009) 
$8,000-$12,000 
(May-Oct 2012) 
$8,000-$8,500 
(2013) 
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2.2 Purity 
Desired Trend: Supply control leads to a decrease in purity. 
 
Comment: The purity of methamphetamine remains high. Data from Environmental Science and Research 
(ESR) testing show purity was declining from 2009 to 2012 but samples from early 2013 show high purity 
levels. Testing by both Customs and Police also suggests that purity remains high. By contrast, it is hard to 
discern a trend from the responses of Police detainees and frequent drug users on their perceptions of purity.  
 
Indicator Source Baseline April 2013 data October 2013 
(new data) 
Methamphetamine 
percentage in seized 
samples (maximum 
purity is 80%) 
 
ESR Methamphetamine 
samples were 68.9% 
pure. 
 
(2006-2009) 
40 samples from 
2011/12 were tested. 
Preliminary results 
for the average purity 
of the 15 border 
seizures was 72% 
pure and for 
domestic seizures 
60% pure. Overall 
average purity was 
65%. 
 
(2012) 
20 point samples 
seized between Dec 
2012 and Mar 2013 
by NZ Police were 
analysed.  The 
median purity was 
found to be 77%.   
 
Final results from 40 
samples taken at the 
border and 
domestically in 2012 
showed median 
purity of 70%.   
 
(Aug 2013) 
Perception of overall 
level of purity as 
reported by frequent 
drug users or Police 
detainees 
IDMS 36% of frequent drug 
users reported purity 
as “high”, 7% as 
“low” and  
39% “fluctuates”.  
 
(2008) 
30% of frequent drug 
users reported purity 
as “high”, 13% as 
“low” and 31% as 
“fluctuates. 
 
(Jul-Dec 2012) 
No new data 
available. 
48% of frequent drug 
users reported purity 
as “fluctuating” in the 
last 6 months and 
29% as “stable”. 
 
(2008) 
30% of frequent drug 
users reported purity 
as “fluctuating” in the 
last 6 months and 
34% as “stable”.  
 
(Jul-Dec 2012) 
No new data 
available. 
NZ-ADUM No data available. 35% of police 
detainees reported 
purity as “high”, 13% 
as “low”, 21% as 
“fluctuates”. 
 
(2012) 
40% of police 
detainees reported 
purity as “high”, 17% 
as “low”, 25% as 
“fluctuates” 
 
(2013) 
Not applicable – 
questions on purity 
were included in NZ-
ADUM for the first 
time in 2012. 
11% of police 
detainees reported 
purity as 
“increasing”, 42% as 
“stable”, 24% as 
“fluctuating” and 23% 
“decreasing”. 
 
(Mar-Jul 2012) 
13% of police 
detainees reported 
purity as 
“increasing”, 39% as 
“stable”, 25% as 
“fluctuating” and 23% 
“decreasing”. 
 
(Mar-Jul 2013) 
  Tackling Methamphetamine: Indicators and Progress Report October 2013 8 
2.3 Availability 
Desired Trend: Supply control makes it harder to obtain methamphetamine. 
 
Comment: These indicators track changes in the perceptions of frequent drug users and Police detainees 
about the availability of methamphetamine. According to them, methamphetamine availability has been fairly 
stable in Auckland and Wellington over the past five years. In contrast, they report a steady decline in the 
availability of methamphetamine in Christchurch since 2007 (which conforms with the higher prices reported 
there).  
 
Indicator Source Baseline April 2013 data October 2013  
(new data) 
Overall availability of 
methamphetamine as 
reported by frequent 
drug users  
 
(Average availability 
scores: 4 = “very easy” 
– 1 = “very difficult” to 
obtain) 
 
(Average change in 
availability score: 1 = 
“more difficult” – 3 = 
“easier” to obtain) 
IDMS Average availability 
score 3.3.  
 
Change in 
availability average 
score: 2.1. 
 
(2009) 
 
42% of frequent 
drug users reported 
availability as “very 
easy”, 0% “very 
difficult”. 
 
(2008) 
Average availability 
score 3.2.  
 
Change in 
availability average 
score: 2.0. 
 
44% of frequent 
drug users reported 
availability as “very 
easy”, 2% “very 
difficult”. 
 
(Jul-Dec 2012) 
 
No new data 
available. 
Overall availability of 
methamphetamine as 
reported by police 
detainees (availability 
scores: 4 =  very easy 
– 1 = very difficult) 
NZ-ADUM No data available. Average availability 
score 3.0. Change 
in availability 
average score: 2.0. 
 
(Mar-Jul 2012) 
Average availability 
score 3.0. Change 
in availability 
average score: 2.1. 
 
(Mar-Jul 2013) 
 
 
Note: This graph indicates responses in the six months prior to the survey (not in the last six months). The most recent 
survey took place between July and December 2012. 
  Tackling Methamphetamine: Indicators and Progress Report October 2013 9 
24% 19% 21% 20%
34% 48% 41% 43%
24%
19% 25% 25%
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
2010 (baseline) 2011 2012 2013
Pe
rc
en
ta
ge
 o
f u
se
rs
Change in availability of methamphetamine in last 6 months as 
reported by Police detainees
(Data source: NZ-ADUM)
Becoming easier to get
No change
Becoming more difficult to get
 
Note: This graph indicates responses in the six months prior to the survey (not in the last six months). The most recent 
survey took place between March and July 2013. 
 
2.4 Manufacturers can’t access the products necessary to make 
methamphetamine 
2.4.1 Seizures 
 
Desired Trend: Supply controls result in an increase in seizures in the interim and eventually a long term 
decrease in seizures.  
 
Comment:  
The amount of ephedrine and pseudoephedrine seized at the border continues to decrease overall (even 
though there have been more border interceptions between January and August this year than in all of 2012). 
The ongoing decline in the quantity of precursors seized is likely to be a reflection of a change in modus 
operandi by the syndicates involved, rather than an indication of reduced quantities entering New Zealand. 
However, seizures of methamphetamine have increased so far this year, reversing the trend from last year. 
China continues to be a major source of methamphetamine and its precursors, but China has been 
strengthening controls over the manufacture, distribution and trade in pseudoephedrine. There has been a 
shortage of iodine and hypophosphorous - the substances required to manufacture methamphetamine in New 
Zealand. This is likely to result in increased attempts at importing finished methamphetamine, involving 
international criminal syndicates. 
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2.4.2 Clandestine lab detections and busts 
 
Desired Trend: The number of clan labs dismantled falls over time as the size of the methamphetamine 
market reduces.  
 
Comment: The overall number of clan labs dismantled has been decreasing. However, much bigger 
“commercial” labs have been dismantled, which probably explains the increasing number of seizures of 
methamphetamine and the increasing quantity of methamphetamine being seized. Clan lab assessments 
have increased steadily over the last four years.1 This may reflect a change in the modus operandi of 
manufacturers i.e. regularly moving equipment and precursors or solvents to evade detection.  
 
                                                
1 Clan lab assessments are where Police have investigated a location where they suspect that methamphetamine is being made. They 
may find some evidence (equipment or ingredients) that suggest that people have been making methamphetamine but they do not find 
the finished product and they cannot establish that it is an operating production lab. 
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Note: The number of clan lab assessments conducted prior to 2006 was not documented. The 2013 clan lab data are provisional.2  
 
2.5 People are deterred from the methamphetamine trade 
2.5.1 Methamphetamine-related convictions 
 
Desired Trend: Supply control increases convictions for supply, dealing and manufacture. Demand reduction 
reduces convictions for possession/use.  
 
Comment: Convictions for manufacturing methamphetamine fell slightly in 2012 from 2011 levels, while 
convictions for supply and/or dealing and possession and/or use rose slightly. The April 2014 report will 
contain 2013 data.  
 
 
 
Note: Figures for 2012 include convictions that have yet to be appealed so are subject to change. Number of convictions is based on 
number of charges. A single offender can have multiple charges and convictions. The 2012 conviction data represents around 1,319 
offenders.  
 
 
 
 
 
                                                
2 The clan lab assessment figures are part of the total figures, e.g. in 2013 to date there were 69 clan lab assessments and 57 clan labs 
dismantled, for a total of 126 known or suspected clan labs. 
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Indicator Source Baseline April 2013 data October 2013  
(new data) 
Numbers of repeat 
offenders 
Ministry of 
Justice 
In 2008, 1,208 
offenders were 
convicted for 
methamphetamine 
offences. Of these, 
267 (or 22.1%) had 
previous 
methamphetamine 
convictions and 189 
(or 15.6%) had been 
previously charged 
but not convicted. 
 
(2008) 
In 2012, 1,319 
offenders were 
convicted for 
methamphetamine 
offences. Of these, 
421 (or 31.9%) had 
previous 
methamphetamine 
convictions and 160 
(or 12.1%) had been 
previously charged but 
not convicted. 
 
(2012) 
No new data 
 
2.5.2 The ability to generate profits is reduced 
 
Comment: The Criminal Proceeds (Recovery) Act 2009 (CPRA) came into effect on 1 December 2009. Since 
then, Police have investigated assets worth an estimated $293 million. Around $70.9 million of this total is 
associated with methamphetamine offending. Police currently hold Restraining Orders over assets worth an 
estimated $135 million. Around $27.4 million of this total has been restrained from respondents associated 
with methamphetamine offences. Since 2009 Police have obtained Forfeiture Orders over assets worth an 
estimated $30.5 million (this is an increase of around $3.6 million since the April 2013 Progress and Indicators 
Report) - $18.7 million of this forfeited total is associated with methamphetamine offences. Due to a number of 
procedural factors3, just over $7 million is currently available to allocate to proposals to fund the expansion of 
alcohol and other drug treatment and additional law enforcement initiatives to fight organised criminal groups 
dealing in methamphetamine and other drugs.  
 
The initial set of proposals to receive CPRA funding includes: 
 analysis of 300 seized methamphetamine samples to assess purity (building on a successful pilot) 
 enhanced frontline screening capability for Customs, including the purchase of a portable substance 
identifier and set up of a laboratory 
 increasing the number of transitional and supported accommodation beds for residential and day 
treatment services, especially in Auckland where there is a particular shortage of these beds 
 funding for counsel to support people accepted into the Alcohol and Drug Treatment Court Pilot 
 training for drug search dogs to detect cash as well, helping to generate more CPRA funds 
 recovery of the legal costs for civil recovery actions under the CPRA for Police, thereby supporting the 
work to disrupt drug, organised crime and gang offending and increasing the amount of money that can 
be returned to the CPRA fund 
 initiatives to reduce the impacts of ‘huffing’ volatile substances, e.g. media guidelines for reporting 
instances of ‘huffing’. 
 
                                                
3 The estimated value of an asset reported is the value of that asset at the point that it is restrained. The final value of the asset can 
only be known at the point of realisation i.e. at the point that the Forfeiture Order is final, all appeals are exhausted, and the asset is sold 
by the Official Assignee. Its final value is only what the buyer is prepared to pay for it. The estimated value of the asset reported is its 
total value. It does not take into account any third party interests that, in line with the legislation, need to be paid out prior to any funds 
being returned to government. This includes spousal interests, mortgages held over an asset, payments made to Legal Aid, any fines or 
reparations owed by the respondent, and the costs incurred by the Official Assignee. Finally, investigations take on average two to three 
years to complete, so there is always an unavoidable lag between the point of restraint to the point of forfeiture. Post forfeiture 
processes also incorporate a minimum of six months to allow for appeals to be heard and possible interested third parties to be 
identified.  
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Part 3: Indicator data for reducing demand 
3.1 Prevalence 
Desired Trend: Decrease in percentage of population using amphetamine (including methamphetamine). 
 
Comment: At 0.9%4 prevalence we remain close to the global average (0.7% based on UN World Drug Report 
2013) for prevalence of use of amphetamine-type substances.  People aged 16-24 years of age had the 
highest past year amphetamine use (2.0%). This is a change from last year (2011/12), where people aged 25– 
34 years were the most likely to report having used amphetamines in the past year (1.9%). The decreased 
monthly usage figure might indicate a smaller population of regular users. 
 
Indicator Baseline Oct 2012 data October 2013  
(new data) 
Prevalence (used 
in last 12 months) 
2.2% total NZ population 
16-64 years. 
 
(2007/08 NZ Alcohol 
and Drug Use Survey) 
0.9% total NZ population 
16-64 years (approx 
25,800 New Zealanders). 
 
Past year amphetamine 
use was highest among 
25-34 year olds (1.9%) 
and higher for males 
(1.3%) than females 
(0.5%). Use did not differ 
significantly by ethnic 
group. 
 
(NZ Health Survey 
2011/12) 
0.9% total NZ population 
16-64 years (approx 
25,000 New Zealanders). 
 
Past year amphetamine 
use was the highest 
among 16-34 year olds 
(2.0% for 16-24 and 1.3% 
for 25-34) and higher for 
males (1.1%) than 
females (0.7%).5 
 
(Provisional NZ Health 
Survey 2012/13 data)   
Prevalence (used 
at least monthly) 
0.4% total NZ population 
16-64 years. 
 
(2007/08 NZ Alcohol 
and Drug Use Survey) 
No data available.  0.2% of total population 
16-64 years; 0.1% among 
females and 0.3% among 
males.6 
 
(Provisional NZ Health 
Survey 2012/13 data) 
Prevalence: young 
users (used at least 
monthly) 
16-17 year olds – 
numbers too low for 
reliable estimation. 18-
24 year olds – 0.8%. 
 
(2007/08 NZ Alcohol 
and Drug Use Survey) 
No data available. 16-17 year olds – 
numbers too low for 
reliable estimation. 18-24 
year olds – 0.8% 
 
(Provisional NZ Health 
Survey 2012/13 data) 
Mean age of user 
(past year) 
No data available. No data available. 28.6 years for the total NZ 
population aged 16-64 
years. 
 
 26.5 – Female7  
 29.9 – Male 
 
(Provisional NZ Health 
Survey 2012/13 data) 
 
 
                                                
4 Note these data are provisional and subject to change.  
5 The difference between males and females is not statistically significant and none of the prevalences reported in this box are 
significantly different from last year.  
6 The difference between males and females is not statistically significant. 
7 The difference between males and females is not statistically significant. 
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3.2 Frequency of use  
Desired Trend: Demand reduction and problem limitation measures lead to a decrease in levels of 
methamphetamine use and frequency of use.  
 
Comment: There is no new data about the frequency of methamphetamine use among regular users. 
However, users continue to report a significant reduction in average frequency of use post-treatment. 
Although hospital data indicate that admissions for methamphetamine-related causes have increased since 
recording began, there is no discernible trend yet with fluctuating admission numbers.8 Any increase in 
admissions could point to an increase in the number of people using methamphetamine. However, it could 
equally be due to: riskier drug taking practices; and/or impurities/other psychoactive substances in the 
methamphetamine; and/or more willingness by users to seek medical help.  
 
Indicator Source Baseline April 2013 data October 2013  
(new data) 
Users who report 
reducing their use 
IDMS Mean use of 38 
days in past 6 
months in 2008 (68 
days in 2007). 
 
(2009) 
Mean use of 51 
days in past 6 
months in 2012. 
 
(Jul-Dec 2012) 
No new data 
available. 
Levels of 
methamphetamine use 
IDMS until 
2010. 
 
NZADUM 
from 2011. 
39% of frequent 
users were using 
less and 13% had 
stopped. 
 
(2009) 
41% of users 
detained by Police 
were using less and 
8% had stopped. 
 
(2011) 
This question was 
discontinued in the 
2013 NZ-ADUM 
(2013). 
Users who have 
received treatment 
report a reduction in 
drug use/frequency of 
use 
Ministry of 
Health 
Average days per 
month of 
amphetamine use 
before treatment: 
8.7 days. 
 
(2010) 
Average days per 
month of 
amphetamine use 
before treatment: 
7.4 days. Average 
days per month of 
amphetamine use 
one month post 
treatment: 0.9 days. 
 
(Nov 2009 – Mar 
2012) 
Average days per 
month of 
amphetamine use 
before treatment: 
6.7 days. Average 
days per month of 
amphetamine use 
one month post 
treatment: 0.7 days.
 
(Nov 20099– June  
2013) 
 
 
                                                
8 The number of hospitalisations is not a count of the number of people, since people can be counted more than once. The primary 
diagnosis is the one established to be chiefly responsible for the patients’ episode of care in hospital. The presence of a drug in the 
secondary diagnosis does not imply that it caused the hospitalisation.  
9 Data is cumulative from the start of the Methamphetamine programme on 1 November 2009, so is not broken out by each time period of 
this report. 
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3.3 Communities are aware of risks 
Desired Trend: Increased awareness of the effects of methamphetamine use, and how to access help. 
 
Comment: There appears to be a good level of awareness regarding the availability, and use of, information 
and resources.  
 
Indicator Source Baseline April 2013 data October 2013  
(new data) 
New Zealanders’ 
attitudes to illegal 
drugs and drug 
use 
Ministry of 
Health 
94% of respondents said 
that methamphetamine is 
a drug causing serious 
harm (compared with 58% 
for cannabis and 39% for 
alcohol). 
 
(2008) 
No new data 
available. 
No new data 
available. 
Use of 
methamphetamine 
information and 
resources 
Ministry of 
Health 
11,451 visits to DrugHelp 
and 3,164 to MethHelp. 
Nearly 4,000 copies of the 
Meth-Help booklet have 
been distributed. 
 
(Aug 2010-Feb 2011) 
27,500 visits to 
MethHelp. Orders 
received for 13,000 
MethHelp booklets. 
 
MethHelp hard-copy 
resource (with DVD) 
is distributed widely 
through treatment 
settings and some 
public health units. It 
is also provided 
directly to affected 
individuals and 
families/ whānau. 
 
(Aug 2010 - Apr 
2013) 
36,240 visits to 
MethHelp. Orders 
received for 15,500 
MethHelp booklets. 
 
Booklets  
distributed to a 
range of services 
including Police, 
treatment 
providers, as well 
as to individuals 
and concerned 
others. 
 
 
(Aug 2010- Sept 
2013) 
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3.4 Users know how to find help 
Desired Trend: Increased awareness and access to help and support.  
 
Comment: Resources available to increase awareness and access to help are well accessed. Connections 
are being promoted between services to increase awareness. For example, the Drug Foundation continues to 
refer direct enquiries about support for methamphetamine issues to the Alcohol and Drug Helpline, as well as 
providing MethHelp booklets to callers.  
 
Indicator Source Baseline April 2013 data October 2013  
(new data) 
Percentage of 
frequent users who 
reported they 
sought help but did 
not receive it 
IDMS 22% in 2008 (32% in 
2007).  
34% in July-December 
2012 (29% in 2011). 
 
(July-December 2012) 
No new data 
available. 
Awareness of 
Alcohol Drug 
helpline by 
methamphetamine 
users 
Alcohol 
Drug 
Helpline 
1,256 
methamphetamine 
related calls, 424 
concerned about 
their own use and 
832 concerned about 
someone else’s use. 
 
(2008/09) 
3,612 
methamphetamine 
related calls since 
November 2009.  Over 
1,228 of those have 
been concerned about 
their own use, and 
nearly 2,384 have 
been calls concerned 
about someone else’s 
use. 
 
(Nov 2009 - Apr 2013) 
4,180 
methamphetamine 
related calls since 
November 2009 (an 
extra 568 since April 
2013).  Of the 
additional callers, 
180 were calling 
about their own use, 
and 388 were calls 
concerned about 
someone else’s use. 
 
(Nov 2009 – Jun 
2013) 
 
3.5 Communities and government agencies help users into treatment 
3.5.1 Access to treatment 
Desired Trend: People seeking treatment are able to access appropriate services as soon as possible.  
 
Comment: There has been a  slight fall in the proportion of frequent methamphetamine users reporting that 
they were in treatment (from 17% in 2011 to 14% in 2012). Frequent users report some increases to the 
barriers to treatment (e.g. long waiting lists). Administrative data show slight improvements in average wait 
times across the country for all alcohol and drug treatment.  
 
A growing number of Police detainees have reported participating in an alcohol and drug treatment 
programme, which the justice system has played an important role in through referrals, diversions and 
sentencing conditions. The proportion of Police detainees who had ever been in a treatment programme 
increased from 38% in 2010 to 46% in 2012 and to 48% in 2013. The proportion who had been in treatment in 
the previous 12 months increased from 16% in 2010 to 21% in 2012, but dropped back to 17% in 2013. 
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Indicator Source Baseline Last reported data October 2013  
(new data)10 
Alcohol and other 
drug (AOD) 
treatment waiting 
times by region as 
reported by 
community alcohol 
and drug services 
DHBs, 
Ministry of 
Health data 
collection, 
ADANZ. 
Northern DHBs – 
4.25 weeks. Midland 
DHBs – 2.6 weeks. 
Central DHBs – 1.3 
weeks. Southern 
DHBs – 8.75 weeks. 
 
(May 2009) 
Northern region - 
88.8% seen within 3 
weeks. Midland region 
- 54.7% seen within 3 
weeks. Central region 
- 60.9% seen within 3 
weeks. Southern 
region - 72.7% seen 
within 3 weeks. 
 
Nationally: 72.8% were 
seen within 3 weeks of 
referral. 
 
(Oct 2011 - Sep 
2012) 
Northern region – 
89.4% seen within 3 
weeks. Midland region 
– 67.9% seen within 3 
weeks  
Central region – 59.7% 
seen within 3 weeks.  
Southern – 71.5% 
were seen within 3 
weeks of referral.  
 
Nationally: 76.3% 
were seen within 3 
weeks.  
 
(July 2012 – June 
2013) 
Data on waiting 
times for residential 
treatment as 
reported by 
providers 
Information 
direct from 
providers. 
Waiting times range 
from 2.5 weeks to 36 
weeks. 
 
(Oct 2009) 
Most clients are 
gaining access to 
dedicated residential 
treatment in less than 
4 weeks. From time to 
time some are waiting 
longer than 8 weeks. 
 
(Apr 2013) 
Most clients are 
gaining access to 
dedicated residential 
treatment in less than 
4 weeks. From time to 
time some are waiting 
longer than 8 weeks. 
 
(Sept 2013) 
Number of 
methamphetamine 
users occupying 
dedicated beds 
Ministry of 
Health 
36 users accessed 
residential treatment. 
17 users accessed 
social detox. 
 
(Jan-Mar 2010) 
528 people accessed 
residential treatment. 
Over 500 people 
accessed social 
detox. 
 
(Nov 2009 - Dec 
2012) 
Over 660 people have 
accessed residential 
treatment, and over 
600 people accessed 
social detox 
 
(Nov 2009-Sept 2013)
Frequent 
methamphetamine 
users who report 
they are receiving 
some forms of drug 
treatment 
IDMS 21% of frequent 
methamphetamine 
users were currently 
in drug treatment. 
 
(2008) 
14% of frequent 
methamphetamine 
users were currently in 
drug treatment in 
2012.11 
 
( Jul-Dec 2012 data) 
No new data 
available. 
 
                                                
10 This is for the full 12 months from July 2012 to June 2013, so there is an overlap with the last reported data. 
11 The last report had used a figure of 30%, which related to users who had ever been in treatment and were currently in treatment, rather 
than methamphetamine users currently in treatment. 
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Indicator Source Baseline Last reported data October 2013  
(new data) 
Frequent 
methamphetamine 
users report 
barriers to being 
able to find help for 
their drug use12 
IDMS 22% of frequent 
users reported 
barriers to finding 
help, including: 
 fear of what 
might happen 
once contact 
made with 
service (45%) 
 social pressure 
to keep using 
(36%) 
 fear of losing 
friends (34%) 
 fear of police 
(27%) 
 didn’t know 
where to go 
(21%) 
 long waiting lists 
(14%) 
 fear of CYF 
(14%) 
 no transport 
(11%). 
 
(2008) 
34% of frequent users 
reported barriers to 
finding help, 
including: 
 other (38%) 
 fear of what 
might happen 
once contact 
made with 
service (21%) 
 social pressure 
to keep using 
(30%) 
 fear of police 
(24%) 
 didn’t know 
where to go 
(27%) 
 long waiting lists 
(32%) 
 no transport 
(23%) 
 concern about 
impact on 
job/career (30%) 
 costs too much 
(21%). 
 
(2012)13 
No new data 
available. 
 
                                                
12 Reported data is from frequent users of all drug types.  
13 The data reported in April 2013 Indicators and Progress Report were incorrect – the correct data are now given. 
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3.5.1 Assistance through the Justice System 
 
Desired Trend:. The number of prisoners and offenders who come in contact with the justice system who are 
referred to treatment or diversionary schemes will increase initially. However, it is expected that there will be a 
fall in numbers in the longer term as treatment leads to fewer frequent users.  
 
Comment: The shifting of methamphetamine trials from the High Court to the District Courts, where there is 
greater capacity, has resulted in shorter waiting times. The Department of Corrections has recently achieved 
its target of at least 1000 prisoners per year commencing rehabilitation in Drug Treatment Units (DTU) to 
address problem alcohol and drug use, although completion rates fell slightly last year. The number of Police 
diversions with alcohol and other drug assessment, treatment or counselling as a condition of sentence has 
declined due to pre-charge warnings being used more, with only the more serious offences proceeding to 
court before being considered for diversion.   
 
Indicator Source Baseline Last reported data October 2013  
(new data) 
Total prisoners who 
start a substance 
abuse programme 
in a Drug 
Treatment Unit 
Corrections 499 (2008/09) 907 (2011/12) 1,026 (2012/13) 
Total hours in 
treatment for 
prisoners 
Corrections 106,097 (2008/09) 172,750 (2011/12) 195,865 (2012/13) 
Completion rates 
(% of prisoners in 
treatment who 
complete) 
Corrections 58% (2008/09) 82% (655 out of 802). 
Not all participants 
who commenced in 
2011/12 completed in 
that year. 
 
(2011/12) 
78% (765 out of 985) 
Not all participants 
who commenced in 
2012/13 completed in 
that year. 
 
(2012/13) 
Number of Adult 
Police Diversion 
Scheme diversions 
with alcohol and 
other drug 
assessment, 
treatment or 
counselling as a 
condition of 
diversion 
Police At least 1,056 
diversions with AOD 
treatment as a 
condition. 
(2008) 
141 - these data may 
not be reliable, due to 
inconsistent data 
entry. The actual 
number of those 
completing AOD 
programmes is likely 
to be higher. 
(1 Sep 2012– 30 Jan 
2013) 
128- the "low" number 
of AOD diversions 
compared to the 
baseline data is a 
result of: 
 the increased 
issuing of formal 
warnings as part 
of the Alternative 
Resolutions 
initiative  
 diversions no 
longer being 
issued for Class A 
and B offences 
since March 2011 
(1 Feb -  31 Aug 2013 
Number of 
offenders with 
methamphetamine 
convictions who 
received an Alcohol 
and Drug 
Assessment as a 
condition of 
sentence 
Ministry of 
Justice 
218 (17.2% of total 
methamphetamine 
convictions). 
(2008) 
301 (22% of total 
methamphetamine 
convictions). 
(2012) 
No new data 
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Glossary 
 
Police detainee – a person held in custody at a Police station for less than 48 hours 
 
Frequent methamphetamine user – someone who uses methamphetamine or crystal methamphetamine on 
a monthly basis 
 
Precursor – substances (like pseudoephedrine (PSE) and ephedrine) that are used to make 
methamphetamine 
 
ContacNT – a cold and flu preparation that is manufactured for China’s domestic market, which consists of 
90mg of pseudoephedrine 
 
Purity – the extent to which methamphetamine hydrochloride is diluted with another substance (Note: the 
maximum purity is 80%)  
 
Clandestine Lab – a location in which methamphetamine is produced 
 
Clan Lab Assessment – Police investigation of a location where it is suspected that methamphetamine is 
being made, equipment or ingredients are found but no finished product or sufficient evidence to confirm the 
existence of an operating production lab 
 
 
 
  Tackling Methamphetamine: Indicators and Progress Report October 2013 22 
ANNEX 1: KEY DATA SOURCES 
 
New Zealand Arrestee Drug Use Monitoring System (NZ-ADUM) and Illicit Drug Monitoring System 
(IDMS)  
The NZ-ADUM and IDMS datasets have different samples and have different purposes. The aim of the IDMS 
is to track recent trends in illegal drug use. It recruits active frequent methamphetamine users. Participants in 
the study have used methamphetamine at least monthly in the previous six months. This ensures that the 
participants have current knowledge of the methamphetamine market based on recent ‘first hand’ experience. 
It also means that they will typically not be in (residential) drug treatment.  
 
The aim of NZ-ADUM is broader – to investigate levels of alcohol and other drug use among police detainees. 
The main criterion for eligibility for the study is detention in a police station for no more than 48 hours. The 
arrestee population has high levels of alcohol and drug use, but not all are frequent drug users. As a result, 
the researchers (who administer both studies) conclude that they know less about current drug trends than 
the frequent drug users in the IDMS study. 
 
Results from each of these studies are available annually; NZ-ADUM data in time for the October six-monthly 
reports and IDMS data in time for the April six-monthly report. As a result, this progress report only has 
updated NZ-ADUM data.  
 
Both studies have relatively small sample sizes. The 2012 IDMS interviewed a total of 330 frequent drug 
users, of which 100 were frequent methamphetamine users. The 2013 NZ-ADUM had a total of 848 
participants. It is important to note that not all participants answer every survey question. 
 
New Zealand Health Survey  
All data are provisional and therefore could be subject to change. 
 
The sample size for those aged 16-64 years in the 2012/13 NZ Health Survey was 9853 (4113 males and 
5740 females). The use of a screening question in 2011/12 could mean that a small number of people 
inadvertently screened themselves out from responding to the subsequent questions about amphetamine use 
(meaning that the 2011/12 prevalence could be a slight underestimate). The questions about past year 
amphetamine use and mean age of amphetamine user were collected face-to-face with an interviewer, while 
past month amphetamine use was self-completed on a computer.  
 
Indicators that will be updated in the April 2014 report 
A number of the indicators in this report use data that are reported annually. As a result, they will not be 
updated until the April 2014 report. These include the following indicators: 
 
 number of repeat offenders (page 12) 
 convictions data (page 12) 
 number of offenders with methamphetamine convictions who received an Alcohol and Drug Assessment 
as a condition of sentence (page 20). 
